Metabolic Syndrome: Definition and Therapeutic Implications
The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Abstract
The collection of impaired glucose metabolism, central obesity, elevated blood pressure, and dyslipidemia is identified as metabolic syndrome (MetS). It is estimated that approximately 25% of the world's population has MetS. In the United States, MetS is more common in men and Hispanics, and its incidence increases with age. Metabolic syndrome increases the risk of developing cardiovascular disease and type 2 diabetes mellitus. The underlying risk factors include insulin resistance and abdominal obesity. Confusion about MetS exists in part due to the lack of a consensus definition and treatment protocol. Treatment of MetS begins with therapeutic lifestyle changes and then pharmacologic treatment of the syndrome's individual components. Effective interventions include diet modification, exercise, and use of pharmacologic agents to treat risk factors. Weight loss and increasing physical activity significantly improve all aspects of MetS. A diet that includes more fruits, vegetables, whole grains, monounsaturated fats, and low-fat dairy products will benefit most patients with MetS. Physicians can be most effective in advising patients by customizing specific lifestyle recommendations after assessing patients for the presence of risk factors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011
Chobanian, A. V., Bakris, G. L., Black, H. R., Cushman, W. C., Green, L. A., Izzo, J. L., Jones, D. W., Materson, B. J., Oparil, S., Wright, J. T., et al. (2003) · Hypertension · doi:10.1161/01.hyp.0000107251.49515.c2 · Cited by 13,271
Grundy, S. M., Cleeman, J. I., Daniels, S. R., Donato, K. A., Eckel, R. H., Franklin, B. A., Gordon, D. J., Krauss, R. M., Savage, P. J., Smith, S. C., et al. (2005) · Circulation · doi:10.1161/circulationaha.105.169404 · Cited by 11,961
Bariatric Surgery: A Systematic Review and Meta-analysis
Buchwald, H., Avidor, Y., Braunwald, E., Jensen, M. D., Pories, W., Fahrbach, K., & Schoelles, K. (2004) · JAMA · doi:10.1001/jama.292.14.1724 · Cited by 6,800
Ford, E. S., Giles, W. H., & Dietz, W. H. (2002) · JAMA · doi:10.1001/jama.287.3.356 · Cited by 6,698
Alberti, K. G. M. M., Zimmet, P., & Shaw, J. (2006) · Diabetic Medicine · doi:10.1111/j.1464-5491.2006.01858.x · Cited by 6,597
Pearson, T. A., Mensah, G. A., Alexander, R. W., Anderson, J. L., Cannon, R. O., Criqui, M., Fadl, Y. Y., Fortmann, S. P., Hong, Y., Myers, G. L., et al. (2003) · Circulation · doi:10.1161/01.cir.0000052939.59093.45 · Cited by 6,401 · cited 6×
“The Prospective Study of Pravastatin in the Elderly at Risk (PROSPER) study of older individuals (aged 70–82 years) failed to show an association between MetS and increased risk of CVD.41 The Casale Monferrato Study, a study in an Italian cohort of older individuals (aged .”
InfluentialSacks, F. M., Svetkey, L. P., Vollmer, W. M., Appel, L. J., Bray, G. A., Harsha, D., Obarzanek, E., Conlin, P. R., Miller, E. R., Simons-Morton, D. G., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200101043440101 · Cited by 5,638
Effect of Rosiglitazone on the Risk of Myocardial Infarction and Death from Cardiovascular Causes
Nissen, S. E., & Wolski, K. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa072761 · Cited by 4,675 · cited 1×
“Nevertheless, there has been concern regarding potential increased risk in CVD outcomes, based on clinical trials with rosiglitazone but not observed with pioglitazone.(80) Although thiazolidinediones increase body weight, they are associated with a reduction in waist-to-hip ratio and improvements in other components…”
Cited by
Menopause-Associated Lipid Metabolic Disorders and Foods Beneficial for Postmenopausal Women
Ko, S.-H., & Kim, H.-S. (2020) · Nutrients · doi:10.3390/nu12010202 · Cited by 516
Meta-analysis of psoriasis, cardiovascular disease, and associated risk factors
Miller, I. M., Ellervik, C., Yazdanyar, S., & Jemec, G. B. E. (2013) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2013.06.053 · Cited by 318
Patisaul, H. B., Roberts, S. C., Mabrey, N., McCaffrey, K. A., Gear, R. B., Braun, J., Belcher, S. M., & Stapleton, H. M. (2013) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.21439 · Cited by 265
Time-restricted feeding and risk of metabolic disease: A review of human and animal studies
Rothschild, J., Hoddy, K. K., Jambazian, P., & Varady, K. A. (2014) · Nutrition Reviews · doi:10.1111/nure.12104 · Cited by 241
A systematic review and meta-analysis of interventions for weight management using text messaging
Siopis, G., Chey, T., & Allman‐Farinelli, M. (2015) · Journal of Human Nutrition and Dietetics · doi:10.1111/jhn.12207 · Cited by 155
Zhu, L., Yang, W. J., Spence, C. B., Bhimla, A., & Ma, G. X. (2021) · Healthcare · doi:10.3390/healthcare9111518 · Cited by 36
“In recent years, MetS has reached epidemic proportions globally [3], affecting approximately one-quarter of the world’s population [6,11].”
BackgroundDushkin, M., Khrapova, M., Kovshik, G., Chasovskikh, M., Menshchikova, E., Trufakin, V., Shurlygina, A., & Vereschagin, E. (2014) · BMC Complementary and Alternative Medicine · doi:10.1186/1472-6882-14-33 · Cited by 25
Metadata
- Authors
- Prasad, H., Ryan, D. A., Celzo, M. F., & Stapleton, D.
- Venue
- Postgraduate Medicine
- Publisher
- Informa UK Limited
- Published
- 2012-01
- Volume
- 124
- Issue
- 1
- Pages
- 21-30
- ISSN
- 0032-5481 (ISSN-L)
- 1941-9260
- OpenAlex
- W2055781340
- Cited by
- 140
- References
- 44
- FWCI
- 12.20
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.